Earnings calls

Sanofi India Limited concall ledger

Every earnings call for SANOFI — management tone, guidance, KPIs and promise tracking, quarter by quarter.

SANOFI · 2 transcripts · Healthcare · latest Q3 FY26

Sanofi India Limited has 2 earnings calls on record here, a Healthcare company, most recently Q3 FY26. Each quarter is scored on revenue, margins, guidance delivery and the questions management left unanswered — so the gap between what was promised and what was delivered is easy to read.

Q3 FY26Published 26 Feb 2026Call held 26 Feb 2026

SANOFI Q3 FY26 Earnings Call Transcript & Analysis

EBITDA Margin21.5%Profit After Tax—+4% YoYEPS₹142

EBITDA Margin (Q4) 21.5%; EPS ₹142. Full year profit before tax increased by 1% and profit after tax by 4%.

Read full transcript & analysis

Q2 FY26Published 29 Oct 2025Call held 29 Oct 2025

SANOFI Q2 FY26 Earnings Call Transcript & Analysis

Diabetes+Partners Growth YTD0.04%Diabetes+Partners Growth QoQ0.05%Partnership Segment Growth YTD0.02%Partnership Segment Growth QoQ0.05%Export Share of Sales0.125%

Diabetes+Partners Growth YTD 0.04%; Diabetes+Partners Growth QoQ 0.05%; Partnership Segment Growth YTD 0.02%. Diabetes + Partners segment grew 4% YTD September 2025 and 5% quarter-to-quarter.

Read full transcript & analysis